Substituting placebo for established, effective therapy: why not?
- PMID: 20547712
- PMCID: PMC2972325
- DOI: 10.1503/cmaj.090548
Substituting placebo for established, effective therapy: why not?
Figures

Similar articles
-
Demonstrating drug action.Am J Psychiatry. 2004 Jun;161(6):943-5. doi: 10.1176/appi.ajp.161.6.943. Am J Psychiatry. 2004. PMID: 15169679 No abstract available.
-
Why use placebos in clinical trials? A narrative review of the methodological literature.J Clin Epidemiol. 2000 Feb;53(2):157-61. doi: 10.1016/s0895-4356(99)00139-0. J Clin Epidemiol. 2000. PMID: 10729687 Review.
-
Placebo surgery in trials of therapy for Parkinson's disease.N Engl J Med. 2000 Feb 3;342(5):354-5. N Engl J Med. 2000. PMID: 10660399 No abstract available.
-
The mousetrap: managing the placebo effect in antidepressant trials.Mol Interv. 2002 Apr;2(2):72-6. doi: 10.1124/mi.2.2.72. Mol Interv. 2002. PMID: 14993352 Review. No abstract available.
-
The importance of considering the effects of perceived group assignment in placebo-controlled trials.Eval Health Prof. 2005 Mar;28(1):5-6. doi: 10.1177/0163278704273085. Eval Health Prof. 2005. PMID: 15677382 No abstract available.
Cited by
-
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.BMJ. 2020 Sep 23;370:m3342. doi: 10.1136/bmj.m3342. BMJ. 2020. PMID: 32967856 Free PMC article.
-
Placebo orthodoxy and the double standard of care in multinational clinical research.Theor Med Bioeth. 2015 Feb;36(1):7-23. doi: 10.1007/s11017-015-9317-9. Theor Med Bioeth. 2015. PMID: 25663050
References
-
- Declaration of Helsinki. Ferney-Voltaire (France): World Medical Association; 2008.
-
- Tri-Council policy statement: ethical conduct for research involving humans. Ottawa (ON): Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada; 1998. [amended 2000, 2002, 2005]
-
- Council for International Organizations of Medical Sciences. International guidelines for biomedical research involving human subjects. Geneva (Switzerland): The Council; 2002. - PubMed
-
- Choice of control group and related issues in clinical trials (E-10) Geneva (Switzerland): International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2000.
-
- Temple R, Ellenberg S. Placebo-controlled trials and active-controlled trials in the evaluation of new treatments. Part1: Ethical and scientific issues. Ann Intern Med. 2000;133:455–63. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources